N ANTISUERO PARA LA Α2-MACROGLOBULINA HUMANA
REACTIVOS DE DIAGNÓSTICO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE LA Α2-MACROGLOBULINA EN SUERO HUMANO, PLASMA HEPARINIZADO Y ORINA. AGENTE DE DIAGNÓSTICO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES
IN VITRO DIAGNOSTIC REAGENTS FOR THE QUANTITATIVE DETERMINATION OF Α2-MACROGLOBULIN IN HUMAN SERUM, HEPARINIZED PLASMA AND URINE. DIAGNOSTIC AGENT. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE Α2-MACROGLOBULINA
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF Α2-MACROGLOBULIN
- Analysis ID
- 775R2019 SSA
- Registration Date
- April 12, 2019
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for N ANTISUERO PARA LA Α2-MACROGLOBULINA HUMANA (N ANTISERUM FOR HUMAN Α2-MACROGLOBULIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 775R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on April 12, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.